Teranode Continues to Build Customer Momentum with New Customer Wins and Existing Site Expansions
Teranode Corporation, the leading innovator of scientific data and workflow management software for the Life Sciences industry, today announced it continues to build customer momentum with the addition of a top five global pharmaceutical company, as well as Tethys Bioscience and Calibrant Biosystems, among others. Teranode also announced that several existing customers, including AstraZeneca, Nastech, NIH Chemical Genomics Center, Pfizer, and St. Jude Children’s Research Hospital, have all expanded its use of the company’s technology. TERANODE XDA, a scientific data and workflow management platform, unifies and reports data across an increasingly diverse set of laboratories.
The unnamed world-leading top five pharmaceutical company selected Teranode’s award-winning platform, TERANODE XDA, to handle lifecycle management of samples and associated data within its pathway research group.
Tethys Bioscience chose TERANODE XDA as a flexible way to handle inventory management, and assay design, along with optimizing the accessibility and analysis of data while minimizing the cost of informatics.
Calibrant Biosystems selected TERANODE XDA as their solution of choice for proteomics data and workflow management in support of quantitative protein biomarker profiling associated with cancer and other human disease.
“Our challenge is to provide scientists the flexibility to change experiments in the laboratory, while ensuring the ability to integrate the results across the project team,” said Paul Rudnick, director of bioinformatics for Calibrant Biosystems. “TERANODE XDA provided a comprehensive, adaptive platform for automating workflow, managing data, and unifying reporting.”
“TERANODE XDA continues to attract the innovators that will shape the use of research technology,” said Neil Fanger, vice president of solutions business development for Teranode. “This elite group of customers provides our company with insights and experiences that link Teranode’s technology vision to customers’ business objectives.”
About Teranode Corporation
Teranode Corporation, a venture-backed company headquartered in Seattle, Washington, is the leading innovator of scientific data and workflow management software that integrates in-silico and lab experimentation. Teranode’s award-winning products are used by leading pharmaceutical, biotechnology, research, and academic organizations, including Pfizer, AstraZeneca, Novartis, NIH Chemical Genomics Center, MIT, and Fred Hutchinson Cancer Research Center, to improve the speed and value of experimentation in R&D and then share chemical and biological knowledge enterprise-wide. For more information, visit http://www.teranode.com .
